Models, mechanisms and clinical evidence for cancer dormancy
暂无分享,去创建一个
[1] P. Kienle,et al. Minimal residual disease in gastrointestinal cancer. , 2001, Seminars in surgical oncology.
[2] Xi C. He,et al. PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention , 2006, Nature.
[3] S. Gestl,et al. Dormant Wnt-Initiated Mammary Cancer Can Participate in Reconstituting Functional Mammary Glands , 2006, Molecular and Cellular Biology.
[4] H. Allgayer,et al. Individual development and uPA–receptor expression of disseminated tumour cells in bone marrow: A reference to early systemic disease in solid cancer , 1995, Nature Medicine.
[5] A. Lin,et al. Suppression of metastatic colonization by the context-dependent activation of the c-Jun NH2-terminal kinase kinases JNKK1/MKK4 and MKK7. , 2005, Cancer research.
[6] O. Liang,et al. A Region in Urokinase Plasminogen Receptor Domain III Controlling a Functional Association with α5β1 Integrin and Tumor Growth* , 2006, Journal of Biological Chemistry.
[7] P. Steeg,et al. Metastasis suppressor genes: basic biology and potential clinical use. , 2003, Clinical breast cancer.
[8] I. Macdonald,et al. Metastasis: Dissemination and growth of cancer cells in metastatic sites , 2002, Nature Reviews Cancer.
[9] M. Wicha. Cancer Stem Cells and Metastasis: Lethal Seeds , 2006, Clinical Cancer Research.
[10] K. Bitter,et al. Postoperative Chemotherapy with Cisplatin and 5-Fluorouracil in Cancer of the Oral Cavity and the Oropharynx - Long-Term Results , 2003, Journal of chemotherapy.
[11] Mitchell D Schnall,et al. Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis. , 2002, Cancer cell.
[12] Ruud H. Brakenhoff,et al. Dissecting the metastatic cascade , 2004, Nature Reviews Cancer.
[13] U. Weidle,et al. Urokinase-catalysed cleavage of the urokinase receptor requires an intact glycolipid anchor. , 2001, The Biochemical journal.
[14] Lars Holmgren,et al. Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression , 1995, Nature Medicine.
[15] Michael E. Greenberg,et al. Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis , 1995, Science.
[16] B. Naume,et al. Minimal Residual Disease in Breast Cancer , 2004, Cancer and Metastasis Reviews.
[17] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[18] O. Volpert,et al. Wiring the angiogenic switch: Ras, Myc, and Thrombospondin-1. , 2003, Cancer cell.
[19] J. Ghiso. Inhibition of FAK signaling activated by urokinase receptor induces dormancy in human carcinoma cells in vivo , 2002, Oncogene.
[20] U. Thorgeirsson,et al. Different regulation of vascular endothelial growth factor expression by the ERK and p38 kinase pathways in v-ras, v-raf, and v-myc transformed cells. , 2000, Biochemical and biophysical research communications.
[21] G. Willimsky,et al. Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance , 2005, Nature.
[22] J. Aguirre-Ghiso,et al. Functional coupling of p38-induced up-regulation of BiP and activation of RNA-dependent protein kinase-like endoplasmic reticulum kinase to drug resistance of dormant carcinoma cells. , 2006, Cancer research.
[23] Jason L. Townson,et al. Ineffectiveness of Doxorubicin Treatment on Solitary Dormant Mammary Carcinoma Cells or Late-developing Metastases , 2003, Breast Cancer Research and Treatment.
[24] J E Talmadge,et al. Evidence for the clonal origin of spontaneous metastases. , 1982, Science.
[25] D. Johnston,et al. Measurement of residual leukemia during remission in childhood acute lymphoblastic leukemia. , 1997, The New England journal of medicine.
[26] W. Muller,et al. Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction. , 2004, Cancer cell.
[27] D. Garigan,et al. Mutations That Increase the Life Span of C. elegans Inhibit Tumor Growth , 2006, Science.
[28] R. Eils,et al. From latent disseminated cells to overt metastasis: Genetic analysis of systemic breast cancer progression , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[29] R. Scheuermann,et al. Cancer dormancy. VII. A regulatory role for CD8+ T cells and IFN-gamma in establishing and maintaining the tumor-dormant state. , 1999, Journal of immunology.
[30] Carlos Cordon-Cardo,et al. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas , 2007, Nature.
[31] I. Weinstein. Addiction to Oncogenes--the Achilles Heal of Cancer , 2002, Science.
[32] Z. Estrov,et al. Persistence of dormant leukemic progenitors during interferon-induced remission in chronic myelogenous leukemia. Analysis by polymerase chain reaction of individual colonies. , 1994, The Journal of clinical investigation.
[33] C. Garbe,et al. Detection of melanoma cells in sentinel lymph nodes, bone marrow and peripheral blood by a reverse transcription–polymerase chain reaction assay in patients with primary cutaneous melanoma: association with Breslow's tumour thickness , 2001, The British journal of dermatology.
[34] A. Zetterberg,et al. Cell-cycle-specific induction of quiescence achieved by limited inhibition of protein synthesis: counteractive effect of addition of purified growth factors. , 1985, Journal of cell science.
[35] M. Goodell,et al. A distinct "side population" of cells with high drug efflux capacity in human tumor cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[36] J. Avruch,et al. TOR Deficiency in C. elegans Causes Developmental Arrest and Intestinal Atrophy by Inhibition of mRNA Translation , 2002, Current Biology.
[37] P. Klatt,et al. Delayed ageing through damage protection by the Arf/p53 pathway , 2007, Nature.
[38] A. Giuliano,et al. Most Early Disseminated Cancer Cells Detected in Bone Marrow of Breast Cancer Patients Have a Putative Breast Cancer Stem Cell Phenotype , 2006, Clinical Cancer Research.
[39] M. Serrano,et al. The power and the promise of oncogene-induced senescence markers , 2006, Nature Reviews Cancer.
[40] W. Gerald,et al. Cyclin D1, a novel molecular marker of minimal residual disease, in metastatic neuroblastoma. , 2007, The Journal of molecular diagnostics : JMD.
[41] M. Koornneef,et al. Seed dormancy and germination. , 2002, Current opinion in plant biology.
[42] P. Pharoah,et al. Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1 , 2005, Nature Genetics.
[43] Kunihiro Matsumoto,et al. The p38 signal transduction pathway participates in the oxidative stress-mediated translocation of DAF-16 to Caenorhabditis elegans nuclei , 2005, Mechanisms of Ageing and Development.
[44] D. Huo,et al. The p38 kinases MKK4 and MKK6 suppress metastatic colonization in human ovarian carcinoma. , 2006, Cancer research.
[45] J. Aguirre-Ghiso,et al. Tumor cell dormancy induced by p38SAPK and ER-stress signaling: An adaptive advantage for metastatic cells? , 2006, Cancer biology & therapy.
[46] C. Larabell,et al. Reversion of the Malignant Phenotype of Human Breast Cells in Three-Dimensional Culture and In Vivo by Integrin Blocking Antibodies , 1997, The Journal of cell biology.
[47] C. Klein,et al. Early cancer cell dissemination and late metastatic relapse: clinical reflections and biological approaches to the dormancy problem in patients. , 2001, Seminars in cancer biology.
[48] J. Folkman. Role of angiogenesis in tumor growth and metastasis. , 2002, Seminars in oncology.
[49] J. Uhr,et al. Cancer dormancy: lessons from a B cell lymphoma and adenocarcinoma of the prostate. , 2007, Advances in cancer research.
[50] R. Weinberg,et al. Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesis. , 2003, Cancer cell.
[51] K. Garrett,et al. Cell Cycle Quiescence of Early Lymphoid Progenitors in Adult Bone Marrow , 2006, Stem cells.
[52] Michael Dean,et al. Tumour stem cells and drug resistance , 2005, Nature Reviews Cancer.
[53] Curzio Ruegg,et al. Anti-angiogenic therapies in cancer: achievements and open questions. , 2007, Bulletin du cancer.
[54] R. Brakenhoff,et al. Minimal Residual Disease in Head and Neck Cancer , 2004, Cancer and Metastasis Reviews.
[55] L. Castilla,et al. Selection of Early-Occurring Mutations Dictates Hormone-Independent Progressionin Mouse Mammary TumorLines , 2006, Journal of Virology.
[56] W. Falk,et al. A primary tumor promotes dormancy of solitary tumor cells before inhibiting angiogenesis. , 2001, Cancer research.
[57] L. Ossowski,et al. EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma. , 2002, Cancer cell.
[58] Kedar S Vaidya,et al. Requirement of KISS1 secretion for multiple organ metastasis suppression and maintenance of tumor dormancy. , 2007, Journal of the National Cancer Institute.
[59] Weiping Zou,et al. Immunosuppressive networks in the tumour environment and their therapeutic relevance , 2005, Nature Reviews Cancer.
[60] A. Kitzis,et al. Persistence of Transcriptionally Silent BCR-ABL Rearrangements in Chronic Myeloid Leukemia Patients in Sustained Complete Cytogenetic Remission , 2001, Leukemia & lymphoma.
[61] W. Ellis,et al. Telomerase activity in disseminated prostate cancer cells , 2006, BJU international.
[62] O. Finn. Human tumor antigens, immunosurveillance, and cancer vaccines , 2006, Immunologic research.
[63] Stuart K. Kim,et al. Global analysis of dauer gene expression in Caenorhabditis elegans , 2003, Development.
[64] S. Rafii,et al. Preparing the "soil": the premetastatic niche. , 2006, Cancer research.
[65] R. Demicheli,et al. Tumour dormancy: findings and hypotheses from clinical research on breast cancer. , 2001, Seminars in cancer biology.
[66] C. Klein,et al. Systemic Cancer Progression and Tumor Dormancy: Mathematical Models Meet Single Cell Genomics , 2006, Cell cycle.
[67] W. Benedict,et al. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. , 1999, Science.
[68] Christopher H. Contag,et al. MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer , 2004, Nature.
[69] James M. Roberts,et al. A New Description of Cellular Quiescence , 2006, PLoS biology.
[70] K. Weinhold,et al. The tumor dormant state. Quantitation of L5178Y cells and host immune responses during the establishment and course of dormancy in syngeneic DBA/2 mice , 1979, The Journal of experimental medicine.
[71] G. Naumov,et al. Cellular expression of green fluorescent protein, coupled with high-resolution in vivo videomicroscopy, to monitor steps in tumor metastasis. , 1999, Journal of cell science.
[72] A. Zetterberg,et al. Kinetic analysis of regulatory events in G1 leading to proliferation or quiescence of Swiss 3T3 cells. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[73] A. Puisieux,et al. Metastasis: a question of life or death , 2006, Nature Reviews Cancer.
[74] G. Esposito,et al. Interruption of tumor dormancy by a transient angiogenic burst within the tumor microenvironment. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[75] M. Lacroix,et al. Significance, detection and markers of disseminated breast cancer cells. , 2006, Endocrine-related cancer.
[76] R. Vessella,et al. Tumor cell dormancy: An NCI workshop report , 2007, Cancer biology & therapy.
[77] W. Ellis,et al. The detection and isolation of viable prostate-specific antigen positive epithelial cells by enrichment: a comparison to standard prostate-specific antigen reverse transcriptase polymerase chain reaction and its clinical relevance in prostate cancer. , 2007, Urologic oncology.
[78] Brian K Rutt,et al. In vivo MRI of cancer cell fate at the single‐cell level in a mouse model of breast cancer metastasis to the brain , 2006, Magnetic resonance in medicine.
[79] G. Schlimok,et al. Disseminated cytokeratin positive tumor cells in the bone marrow of patients with prostate cancer: detection and prognostic value. , 2001, The Journal of urology.
[80] Philip Lijnzaad,et al. An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas , 2005, Nature Genetics.
[81] Tanja Fehm,et al. Circulating Tumor Cells in Patients with Breast Cancer Dormancy , 2004, Clinical Cancer Research.
[82] N. Crawford,et al. Germline polymorphisms in SIPA1 are associated with metastasis and other indicators of poor prognosis in breast cancer , 2006, Breast Cancer Research.
[83] G. Naumov,et al. Solitary cancer cells as a possible source of tumour dormancy? , 2001, Seminars in cancer biology.
[84] E. Passegué,et al. Sustained regression of tumors upon MYC inactivation requires p53 or thrombospondin-1 to reverse the angiogenic switch , 2006, Proceedings of the National Academy of Sciences.
[85] R. Vessella,et al. Detection and characterization of circulating and disseminated prostate cancer cells. , 2007, Frontiers in bioscience : a journal and virtual library.
[86] R. Marches,et al. Cancer Dormancy from Mice to Man: A Review , 2006, Cell cycle.
[87] H. Allgayer,et al. Urokinase plasminogen activator receptor (uPA-R): one potential characteristic of metastatic phenotypes in minimal residual tumor disease. , 1997, Cancer research.
[88] G. Semenza. Targeting HIF-1 for cancer therapy , 2003, Nature Reviews Cancer.
[89] J. McCall,et al. Detection and significance of minimal residual disease in colorectal cancer. , 1999, Histology and histopathology.
[90] Masashi Narita,et al. Reversal of human cellular senescence: roles of the p53 and p16 pathways , 2003, The EMBO journal.
[91] G. Bastert,et al. Enrichment of memory T cells and other profound immunological changes in the bone marrow from untreated breast cancer patients , 2001, International journal of cancer.
[92] D. Theodorescu,et al. Metastasis Suppressor Proteins: Discovery, Molecular Mechanisms, and Clinical Application , 2006, Clinical Cancer Research.
[93] J. Aguirre-Ghiso,et al. Urokinase receptor and fibronectin regulate the ERK(MAPK) to p38(MAPK) activity ratios that determine carcinoma cell proliferation or dormancy in vivo. , 2001, Molecular biology of the cell.
[94] C. Pott,et al. Significance of Minimal Residual Disease in Lymphoid Malignancies , 2004, Acta Haematologica.
[95] C. Maley,et al. Cancer is a disease of clonal evolution within the body1–3. This has profound clinical implications for neoplastic progression, cancer prevention and cancer therapy. Although the idea of cancer as an evolutionary problem , 2006 .
[96] A. Fornace,et al. p38 MAP kinase's emerging role as a tumor suppressor. , 2004, Advances in cancer research.
[97] P. Beckhove,et al. Maintenance of long‐term tumour‐specific T‐cell memory by residual dormant tumour cells , 2005, Immunology.
[98] I. Roninson,et al. Tumor cell senescence in cancer treatment. , 2003, Cancer research.
[99] V. Velculescu,et al. Homozygous deletion of MKK4 in ovarian serous carcinoma , 2006, Cancer biology & therapy.
[100] D. Miller,et al. The tumor dormant state. Comparison of L5178Y cells used to establish dormancy with those that emerge after its termination , 1979, The Journal of experimental medicine.
[101] D J Ferguson,et al. Dormancy of mammary carcinoma after mastectomy. , 1999, Journal of the National Cancer Institute.
[102] K. Miura,et al. Interaction of KAI1 on tumor cells with DARC on vascular endothelium leads to metastasis suppression , 2006, Nature Medicine.
[103] S. Groshen,et al. GRP78 as a novel predictor of responsiveness to chemotherapy in breast cancer. , 2006, Cancer research.
[104] V. Robinson,et al. Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site. , 2003, The Journal of urology.
[105] J. Aguirre-Ghiso,et al. ERKMAPK Activity as a Determinant of Tumor Growth and Dormancy; Regulation by p38SAPK , 2003 .
[106] D. Felsher,et al. Reversible tumorigenesis by MYC in hematopoietic lineages. , 1999, Molecular cell.
[107] Stuart K. Kim,et al. A role for SIR-2.1 regulation of ER stress response genes in determining C. elegans life span. , 2005, Developmental cell.
[108] P. Steeg. Metastasis suppressors alter the signal transduction of cancer cells , 2003, Nature Reviews Cancer.
[109] Sophie Lelièvre,et al. beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium. , 2002, Cancer cell.
[110] Sally Temple,et al. Endothelial Cells Stimulate Self-Renewal and Expand Neurogenesis of Neural Stem Cells , 2004, Science.
[111] H. Kitano. Cancer as a robust system: implications for anticancer therapy , 2004, Nature Reviews Cancer.
[112] Lewis A. Chodosh,et al. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis , 2007, Nature Cell Biology.
[113] S. Groshen,et al. Expression of Stress Response Protein Grp78 Is Associated with the Development of Castration-Resistant Prostate Cancer , 2006, Clinical Cancer Research.
[114] M. Bissell,et al. Extracellular matrix signaling: integration of form and function in normal and malignant cells. , 1998, Current opinion in cell biology.
[115] L. Akslen,et al. Role of Angiogenesis in Human Tumor Dormancy: Animal Models of the Angiogenic Switch , 2006, Cell cycle.
[116] F. Gounari,et al. EblacZ tumor dormancy in bone marrow and lymph nodes: active control of proliferating tumor cells by CD8+ immune T cells. , 1998, Cancer research.
[117] A. Al-Mehdi,et al. Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis , 2000, Nature Medicine.
[118] A. Rougvie,et al. C. elegans DAF-18/PTEN Mediates Nutrient-Dependent Arrest of Cell Cycle and Growth in the Germline , 2006, Current Biology.
[119] K. Pantel,et al. Disseminated tumor cells: diagnosis, prognostic relevance, and phenotyping. , 2001, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[120] H. Huland,et al. Detection of tumor‐specific DNA in blood and bone marrow plasma from patients with prostate cancer , 2007, International journal of cancer.
[121] E. Fuchs,et al. Defining the Epithelial Stem Cell Niche in Skin , 2004, Science.
[122] R. Morimoto,et al. Caenorhabditis elegans OSR-1 Regulates Behavioral and Physiological Responses to Hyperosmotic Environments , 2004, Genetics.
[123] Sanjay Shete,et al. uPAR and HER-2 gene status in individual breast cancer cells from blood and tissues , 2006, Proceedings of the National Academy of Sciences.
[124] J. Izbicki,et al. Minimal residual disease in non-small-cell lung cancer. , 2001, Seminars in surgical oncology.
[125] H. Allgayer,et al. Minimal residual disease in gastric cancer: evidence of an independent prognostic relevance of urokinase receptor expression by disseminated tumor cells in the bone marrow. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[126] K. Hunter,et al. Host genetics influence tumour metastasis , 2006, Nature Reviews Cancer.
[127] A. Matsuzawa,et al. Survival of leukemic cells in a dormant state following cyclophosphamide‐induced cure of strongly immunogenic mouse leukemia (DL811) , 1991, International journal of cancer.
[128] L. Ossowski,et al. Tumor Dormancy Induced by Downregulation of Urokinase Receptor in Human Carcinoma Involves Integrin and MAPK Signaling , 1999, The Journal of cell biology.
[129] David Zurakowski,et al. A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype. , 2006, Journal of the National Cancer Institute.
[130] G. Lozano,et al. Differential roles of p21(Waf1) and p27(Kip1) in modulating chemosensitivity and their possible application in drug discovery studies. , 2001, Molecular pharmacology.
[131] G. Naumov,et al. Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancy. , 2002, Cancer research.